Li She
Pfizer (United States)(US)Institute of Laboratory Animal Science(CN)
Publications by Year
Research Areas
Diabetes Treatment and Management, Regulation of Appetite and Obesity, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Crystallization and Solubility Studies
Most-Cited Works
- → Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors(2011)133 cited
- → Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action(1999)65 cited
- → Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation(2000)60 cited
- → PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy(2013)52 cited
- → C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclization(2010)43 cited
- → Discordant Effects of Glucosamine on Insulin-stimulated Glucose Metabolism and Phosphatidylinositol 3-Kinase Activity(1999)41 cited
- → Pharmacodynamic Model of Sodium–Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology(2011)36 cited
- → Aging does not contribute to the decline in insulin action on storage of muscle glycogen in rats(2000)29 cited
- → Identification of (R)-6-(1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic Acid, a Highly Potent and Selective Nonsteroidal Mineralocorticoid Receptor Antagonist(2014)27 cited
- → In Vitro and in Vivo Characterization of 3-{2-[6-(2-tert-Butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl}benzonitrile Hydrochloride Salt, a Potent and Selective NPY5 Receptor Antagonist(2003)25 cited